| | 62666-20-0 Basic information More.. |
| Product Name: | Progabide | | Synonyms: | progabide;BUTANAMIDE, 4-[[(4-CHLOROPHENYL)(5-FLUORO-2-HYDROXYPHENYL)METHYLENE]AMINO]-;Halogabide;(E)-4-((4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methyleneamino)butanamide;4-[[(Z)-(4-Chlorophenyl)-(3-fluoro-6-oxo-1-cyclohexa-2,4-dienylidene)methyl]amino]butanamide;4-[[(4-Chlorophenyl)(5-fluoro-2hydroxyphenyl)methylene]amino]butanamide;C-abren(e);SL-76．002 | | CAS: | 62666-20-0 | | MF: | C17H16ClFN2O2 | | MW: | 334.77 | | EINECS: | 263-679-4 | | Mol File: | 62666-20-0.mol |  |
Use
Progabide, an anticonvulsant, was introduced in France in 1985
for the treatment of epilepsy. Its use has occasionally been associated with
clinically evident signs of icteric hepatitis developing within the first six months of
treatment. These signs are generally reversible on withdrawal of the drug but
continuation of treatment has been associated with three reported fatalities (two of
which are doubtfully related to the drug). The manufacturer revised the data sheet
in March 1986 advising that use of progabide should be reserved for patients
unresponsive to other anticonvulsants.
- Progabide USP/EP/BP
-
- US $1.10 / g
- 2021-07-23
- CAS:62666-20-0
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
|
|
62666-20-0
Recommend Suppliers |
|